Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical

Immunology (SIAAIC) by Heffler, E et al.
Heffler et al. Clin Mol Allergy  (2015) 13:28 
DOI 10.1186/s12948-015-0034-8
RESEARCH
Choosing wisely in Allergology: a Slow 
Medicine approach to the discipline promoted 
by the Italian Society of Allergy, Asthma 
and Clinical Immunology (SIAAIC)
Enrico Heffler1*, Massimo Landi2, Silvana Quadrino3,6, Cristoforo Incorvaia4, Stefano Pizzimenti5, 
Sandra Vernero6, Nunzio Crimi1, Giovanni Rolla7 and Giorgio Walter Canonica8
Abstract 
Background: One of the main problem health care systems are facis is the mis-use and over-use of medical 
resources (including useless exams, surgical interventions, medical treatments, screening procedures…) which may 
lead to high health care related costs without increased patients’ benefit and possible harm to the patients them-
selves. The “Choosing wisely” campaign, in Italy denominated “Doing more does not mean doing better”, tries to 
educate doctors and citizens at a correct use of medical resources.
Methods: the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) adhered to the “Doing more does 
not mean doing better” campaing and made a list of the 5 allergological procedures with the highest evidence of 
inappropriateness.
Results: the 5 recommendations were: “Do not perform allergy tests for drugs (including anhestetics) and/or foods 
when there are neither clinical history nor symptoms suggestive of hypersensitivity reactions”; “Do not perform the 
so-called “food intolerance tests” (apart from those which are validated for suspect celiac disease or lactose enzymatic 
intolerance)”; “Do not perform serological allergy tests (i.e.: total IgE, specific IgE, ISAC) as first-line tests or as “screening” 
assays”; “Do not treat patients sensitized to allergens or aptens if there is not a clear correlation between exposure to 
that specific allergen/apten and symptoms suggestive of allergic reaction”; “Do not diagnose asthma without having 
performed lung function tests”.
Conclusions: An important role scientific societies should play is to advise on correct diagnostic and therapeutical 
pathways. For this reason SIAAIC decided to adhere to the Slow Medicine Italy campaign “Doing more does not mean 
doing better” with the aim of warning the scientific community and the citizens/patients about some allergological 
procedures, which, when performed in the wrong clinical setting, may be not only useless, but unnecessarily expen-
sive and even harmful for patients’ health.
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Background
The concept of “Slow Medicine” has been coined by 
Dr. Alberto Dolara, an Italian cardiologist that in 2002 
invited his colleagues to give the deserved value to the 
time spent in improving the patient-doctor relationship, 
implementing a more “human and thoughtful medicine” 
[1], but these underlying ideas were somehow anticipated 
from some phylosophers such as Ivan Illich that, with his 
“Medical nemesis” published in 1974, argued that the 
medicalization in recent decades of so many of life’s vicis-
situdes—including birth and death—and the so called 
“hubris of medicine” frequently caused more harm than 
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good and rendered many people in effect lifelong patients 
[2].
In the last few years, we assisted to a worldwide dramatic 
increase in interest in the “Slow Medicine” concept, and 
this was also endorsed by the former British Medical Jour-
nal (BMJ) editor in chief, professor Richard Smith, which 
wrote: “slow medicine—like slow food and slow lovemak-
ing—is the best kind of medicine for the 21st century” [3].
One of the main problem the “Slow Medicine” 
approach is trying to face to promote possible solutions, 
is the mis-use and over-use of medical resources (includ-
ing useless exams, surgical interventions, medical treat-
ments, screening procedures…) which is well known 
to lead to both high health care related costs without 
increased patients’ benefit [4] and possible harm to the 
patients themselves [5, 6].
Into this context, the “Choosing wisely” campaign 
started in the USA in 2012 [7, 8] and then spread in sev-
eral other countries, including Italy with the name “Doing 
more does not mean doing better” (“Fare di più non sig-
nifica fare meglio” in Italian) [9–11], has the main goal of 
identifying the most probable inappropriate medical pro-
cedures for each specialty, protecting patients’ interests 
through a partnership between health professionals and 
patients and users [12].
In order to create an accurate list of the five medical 
procedures with the highest probability of inappropriate-
ness for each specialty, Slow Medicine Italy [13] invited 
the most relevant Italian scientific societies to adhere to 
the “Doing more does not mean doing better” campaign. 
The Italian Society of Allergy, Asthma and Clinical Immu-
nology (SIAAIC), the largest Italian scientific society in 
the field with more than 700 active members, enthusi-
astically adhered to the campaign. In this article we will 
described and discuss the methodology used and the 
obtained results to make the list of five allergological pro-
cedures with the highest probability of inappropriateness.
Methods
After formal adhesion of SIAAIC to the “Doing more 
does not mean doing better” campaign, a working 
group of senior and junior members of the Society 
and experts in the field of Allergology has been estab-
lished. The board discussed and identified a first list 
of allergological procedures with a possible high 
degree of inappropriateness. The board members per-
formed an extensive search on PubMed and Cochrane 
Database, without any limit of age, gender or time of 
publication, in order to find enough evidence of inap-
propriateness for each identified allergological proce-
dure (search keywords were depending on the subjects 
of the identified allergologica procedures; all types of 
articles were included into the evaluation), selecting 
the five with the highest evidence of inappropriate-
ness taking also in consideration the frequency and the 
social impact of each of them, and reporting them as 
a “do not” suggestion. The list of the identified 5 most 
inappropriate allergological procedures is reported in 
Table 1.
This list has been approved by both the Executive Com-
mittees of SIAAIC and Slow Medicine Italy, published on 
their websites [14, 15] and spread as a poster sent to all 
SIAAIC members.
Results and discussion
We here briefly discuss each of the identified 5 most 
inappropriate allergological procedures.
Do not perform allergy tests for drugs (including 
anhestetics) And/or foods when there are neither clinical 
history nor symptoms suggestive of hypersensitivity 
reactions
In absence of clinical history or symptoms suggestive of 
hypersensitivity reactions (i.e.: urticaria, angioedema, 
other typical muco-cutaneous manifestations, hypoten-
sion, respiratory symptoms, contemporary involvement 
of two or more organs, or any other consisting organ 
damage) allergometric tests do not have any clinical value 
and have a poor predictive value of future allergic reac-
tions [16]. In this context, a positive allergometric test 
indicates only an immunological sensitization to the 
tested antigen.
Table 1 The list of identified 5 most inappropriate allergological procedures
Do not perform allergy tests for drugs (including anhestetics) and/or foods when there are neither clinical history nor symptoms suggestive of hyper-
sensitivity reactions
Do not perform the so-called “food intolerance tests” (apart from those which are validated for suspect celiac disease or lactose enzymatic intolerance)
Do not perform serological allergy tests (i.e.: total IgE, specific IgE, component-resolved diagnosis) as first-line tests or as “screening” of inhalant & food 
immediate hypersensitivity assays
Do not treat patients sensitized to allergens or aptens if there is not a clear correlation between exposure to that specific allergen/apten and symptoms 
suggestive of allergic reaction. This recommendation is particularly strong for allergen immunotherapy and elimination diets
Do not diagnose asthma without having performed lung function tests (including bronchodilating test and/or bronchial challenge)
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On the other hand, a negative test is indicative only 
of the current absence of sensitization but it does not 
exclude the possibility of future allergic reactions.
The harms connected to this procedure are:
1. Non adequate therapeutical approaches (including 
diets [16]) which are potentially harmful because 
they may preclude the use of drugs or the assump-
tion of foods the patient is not allergic to;
2. it has been described, in two small non randomized 
controlled trials and therefore with low quality of 
evidence, the possibility of new sensitizations to the 
tested antigens induced by the tests themselves [17, 
18].
Do not perform the so‑called “food intolerance tests” 
(apart from those which are validated for suspect celiac 
disease and lactose enzymatic intolerance)
Several assays and techniques are constantly proposed 
to many patients to identify supposed food intolerance. 
These methods include, for example, VEGA-test, Cyto-
toxic test, serum specific IgG4 dosage, chemical analysis 
of hair, applied kinesiology, iridology, and “bioresonance” 
analysis. None of these methods reached sufficient evi-
dence of efficacy, accuracy and repeatability in diagnosis 
food allergy/intolerance [19–28].
The use of these methods, giving unreliable and not 
clinically relevant results, put the patient at risk of inap-
propriate diets which are potentially harmful for health, 
without finding a solution to the symptoms reported by 
the patient [29, 30].
This recommendation is particularly important in a 
context of non adequate perception and knowledge of 
food allergy/intolerance symptoms by both patients and 
general practitioners [31].
Do not perform serological allergy tests (i.e.: total ige, 
specific ige, component‑resolved diagnosis) as first‑line 
tests or as “screening” of inhalant and food immediate 
hypersensitivity assays
Cutaneous allergometric tests, if possible, should be con-
sidered as the first diagnostic tests in case of consisting 
clinical history and symptoms with a suspect allergic 
reaction, as they give faster results, they are less invasive 
and cheaper than serological tests. Moreover, there is a 
moderate evidence that, at least for food allergies, that 
skin tests have at least the same diagnostic accuracy of 
serological tests [32, 33].
Exceptions to this recommendations are:
1. Situations in which cutaneous tests are not feasible, 
such as hypo- or hyper-reactive cutaneous states (i.e.: 
chronic assumption of antihistamines or systemic 
corticosteroids, or the presence of frank dermogra-
phism);
2. Non availability of any accurate extracts to perform 
skin tests against the availability of serological tests 
for the same allergen [16, 34].
3. When the clinical history suggests an unusually 
greater risk of anaphylaxis from skin testing [35].
Total IgE assessment is of limited clinical utility in most 
of the cases, as it is not necessarily indicative of allergic 
sensitization: allergic patients may have both normal or 
elevated total IgE levels, and patients with high total IgE 
levels are not necessarily atopic subjects [16, 34, 36].
Measuring total IgE is otherwise indicated for the diag-
nosis of allergic bronchopulmonary aspergillosis, hyper 
IgE syndrome, as well for verification that the patient 
with severe allergic asthma is a suitable candidate for 
anti-IgE therapy with total serum IgE levels between 30 
and 1500 IU/ml.
Moreover, all serum allergological tests should be 
interpreted by specialists/experts in Allergy and Clini-
cal Immunology as a wrong interpretation can lead a 
non expert doctor to offer therapeutical and/or dietetical 
inappropriate approaches which may be harmful for the 
patient’s health.
Do not treat patients sensitized to allergens or aptens 
if there is not a clear correlation between exposure 
to that specific allergen/apten and symptoms suggestive 
of allergic reaction. This recommendation is particularly 
strong for allergen immunotherapy and elimination diets
The finding of a positive allergometric test for an allergen 
or apten whose exposure is not associated with symp-
toms compatible with allergic reaction is only indicative 
of immunological sensitization and not necessarily of 
clinical manifestations related to hypersensitivity reac-
tion [16, 34]. Therefore, there is no indication to treat 
these patients.
Moreover, as far as food allergy, given the limitation of 
cutaneous and serological tests, oral food challenges (ide-
ally Double-Blind Placebo-Controlled Food-Challenges) 
are still the gold standard in IgE and non IgE medi-
ated food allergy in order to establish a firm diagnosis, 
determine threshold reactivity, assess tolerance and the 
response to immuno-modulation [37].
Suggesting a treatment (including immunotherapic or 
dietetic strategies) to these patients may expose them 
to the risk of useless and potentially harmful therapies 
[38–40].
In particular, elimination diets, when they are not indi-
cated, may expose the patient to nutritional deficiencies 
with no improvement of symptoms for which the allergo-
metric investigations had been carried out [39, 40].
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Do not diagnose asthma without having performed lung 
function tests (including bronchodilating test and/or 
bronchial challenge)
To rely only upon asthma-like symptoms (i.e.: dyspnea, 
chest tightness, cough, wheezing) is not sufficient to 
make a correct diagnosis of asthma, as these symptoms 
may be from alternate causes, such as chronic obstruc-
tive pulmonary disease (COPD), congestive heart failure, 
extrathoracic airway hyperresponsiveness syndromes 
(e.g. vocal cord dysfunction, VCD), gastroesophageal 
reflux disease, hyperventilation syndrome etc. [41–44]. 
This behavior can be harmful for patients as they may 
be receive a wrong treatment for their complaints; this 
is particularly important when patients are affected by 
other relevant comorbidities as it happens in elderly [45].
International asthma guidelines stress the need of per-
forming complete lung function assessment to identify 
bronchial hyperreactivity and/or reversibility of bron-
chial obstruction [46]. Patients with asthma-like symp-
toms and normal spirometry should underwent to an 
aspecific bronchial challenge (i.e.: with methacholine) 
while those with an obstructive spirometric pattern 
should be evaluated for the degree of reversibility dur-
ing a bronchodilating test (i.e.: with salbutamol). Beyond 
the increased costs of care, the consequences of misdiag-
nosing asthma include delaying a correct diagnosis and 
treatment [43].
Conclusions
In this article we described the methodology used and 
the obtained results to make the list of five allergologi-
cal procedures with the highest probability of inappro-
priateness [14, 15], in the context of the “Doing more 
does not mean doing better” campaign proposed by Slow 
Medicine Italy [9–11]. The five selected procedures were 
identified by an expert panel of senior and junior Italian 
allergologists.
The modern medicine is imbued with inappropri-
ate medical procedures, wastes, conflicts of interest and 
fraud deriving from the economic and financial interac-
tions between prescribers, purchasers of health tech-
nologies and the industry [13]. Another important cause 
which may induce the doctors to order inappropri-
ate procedures lies in malpractice claims from patients 
(defensive medicine). This behavior is often encouraged 
by the message, which comes from the “media” and eas-
ily received by patients, that in medicine “more is always 
better” and that “doing less is always an index of medical 
malpractice” [47].
An important role scientific societies should play is 
to produce and disseminate Diagnostic-Therapeutic-
Healthcare Protocols/Pathways, based on the best evi-
dence based scientific knowledge, to guarantee the 
patients receive the correct diagnosis and the appropri-
ate treatment. For this reason SIAAIC decided to adhere 
to the Slow Medicine Italy campaign “Doing more does 
not mean doing better” with the aim of warning the sci-
entific community and the citizens/patients about some 
allergological procedures, which, when performed in 
the wrong clinical setting, may be not only useless, but 
unnecessarily expensive and even harmful for patients’ 
health.
We think that doctors and patients should take more 
time to define together the most appropriate pathway 
which lead to the right diagnosis and to the most appro-
priate treatment. Doctors should always explain the 
patients what the exams they order mean in case they 
turned normal or altered and why some exams are not 
useful at all for the specific diagnosis the patients are 
looking for. An open and trustful patient-physician rela-
tionship appears to be important to avoid useless exams 
and to achieve more accurate diagnoses .
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